1. Changes in Percutaneous Absorption of Fentanyl Patches in Rats Treated with a Sebum-Like Secretion
- Author
-
Tsumugi Eifuku, Noriaki Nagai, Tomonori Hayashi, Hinako Kawaguchi, Atsufumi Kawabata, and Hiroshi Matsuoka
- Subjects
Male ,medicine.medical_specialty ,Administration, Topical ,Skin Absorption ,Absorption (skin) ,Fentanyl ,In vivo ,Internal medicine ,Drug Discovery ,medicine ,Animals ,Secretion ,Rats, Wistar ,Lubricants ,integumentary system ,Chemistry ,General Chemistry ,General Medicine ,Dietary Fats ,In vitro ,Rats ,Analgesics, Opioid ,Sebum ,Drug Liberation ,Endocrinology ,Opioid ,Percutaneous absorption ,Ex vivo ,medicine.drug - Abstract
The percutaneous absorption of a fentanyl (FEN)-patch is affected by various external factors including the volume of sebum secretion, which causes changes in the skin surface environment. In this study, we prepared a lard-based sebum-like secretion (SLS), and applied it to investigate the effect of different skin surface conditions on the drug penetration of a FEN-patch. In vitro work to test drug release using the Franz diffusion cell indicated that drug release was significantly suppressed by treatment with 5% SLS, which is equivalent to the amount of daily human sebum secretion. Conversely, in ex vivo experiments using rat skin, the amount of FEN that accumulated in the skin tissue of the 5% SLS-treated rats was higher in comparison with the non-SLS treated group. Furthermore, in vivo experiments indicated that the plasma FEN concentration in rats treated with the FEN-patch was significantly increased by treatment with 5% SLS. These results suggest that the sebum affected the release, accumulation, and absorption of FEN from the FEN-patch, and the FEN concentration in the blood was reflected by the balance of the suppression of drug release and the enhancement of drug accumulation in the skin with SLS.
- Published
- 2020